SCHEDULE: FMR LLC Reduces Chemours Co Stake to 3.4%

Sentiment:

Beneficial Ownership Statement


FMR LLC and Abigail P. Johnson reported a 3.4% beneficial ownership stake in Chemours Co common stock as of June 30, 2025, held for passive investment purposes.

Worse than expectedFMR LLC's beneficial ownership in Chemours Co decreased to 3.4%, falling below the 5% threshold, indicating a reduction in their position from previous filings.

Summary

  • FMR LLC and Abigail P. Johnson collectively reported beneficial ownership of 5,101,253.50 shares of Chemours Co common stock.
  • This represents 3.4% of the total outstanding common stock of Chemours Co.
  • FMR LLC holds sole voting power over 5,017,444.49 shares and sole dispositive power over 5,101,253.50 shares.
  • Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to have sole dispositive power over 5,101,253.50 shares.
  • The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Chemours Co.
  • This filing is Amendment No. 15, indicating a change from previous beneficial ownership reports where the stake was likely above 5%.

Sentiment

Score: 4

Explanation: The reduction of FMR LLC's beneficial ownership in Chemours Co to 3.4%, falling below the 5% threshold, suggests a decreased position by a major institutional investor, which can be viewed as a slightly negative signal.

Positives

  • FMR LLC, a prominent institutional investor, maintains a significant beneficial ownership stake of 3.4% in Chemours Co, indicating continued, albeit reduced, investment interest.

Negatives

  • FMR LLC's beneficial ownership stake in Chemours Co has decreased to 3.4%, falling below the 5% threshold, which may be interpreted as a reduction in conviction or a reallocation of capital by a major institutional investor.

Future Outlook

This filing is a beneficial ownership statement and does not contain forward-looking statements or guidance regarding Chemours Co's future performance or outlook.

Industry Context

This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive dynamics within the chemical sector. It primarily reflects an investment decision by FMR LLC.

Stakeholder Impact

  • Shareholders: The reduction in a major institutional investor's stake may influence market perception and potentially the stock price, signaling a change in institutional conviction.

Key Dates

DateDescription
2023-05-23Effective date of Power of Attorney for FMR LLC and Abigail P. Johnson.
2023-08-08Date of previous Schedule 13G filing by FMR LLC (accession number: -23-002397) referenced for Power of Attorney.
2025-06-30Date of event which requires filing of this statement (measurement date for beneficial ownership).
2025-08-05Signature date of the Schedule 13G Amendment No. 15 filing.

Recommendation

hold

The filing is a passive ownership disclosure indicating a reduction in a major institutional investor's stake below 5%. While not a strong sell signal, it suggests a decreased conviction or reallocation of capital by FMR LLC, warranting a 'hold' position for existing investors to monitor future developments rather than initiating new positions.

Keywords

Chemours Co, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Common Stock, Institutional Investment, Schedule 13G, Chemicals

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.